首页|微血管减压术对原发性三叉神经痛的治疗效果分析

微血管减压术对原发性三叉神经痛的治疗效果分析

扫码查看
目的 分析原发性三叉神经痛患者行微血管减压术治疗的效果。方法 120 例三叉神经痛患者,均行微血管减压术治疗。分析患者血管压迫情况、治疗效果、不良事件发生情况及复发情况。结果 120 例患者中有责任血管患者 104 例(86。67%),未发现明确有责任血管患者 16 例(13。33%);患者手术有效率为 95。83%(115/120)。术后 1 个月内,患者出现面部麻木 17 例(14。17%),头晕 6 例(5。00%),脑脊液漏 1 例(0。83%),恶心、呕吐 5 例(4。17%),未发生神经麻痹性角膜炎、听力减退等情况。术后 6 个月,有 6 例(5。00%)患者在 3 个月内复发,但给予药物后疼痛症状均能够控制;9 例(7。50%)患者在术后 6 个月内复发,其中 2 例给予药物后未能控制,其余患者病情均稳定,随访头颅CT 均无明显异常,日常生活不受影响。结论 微血管减压术治疗原发性三叉神经痛的效果较为明显,并且相对安全,值得临床推广。
Analysis of effect of microvascular decompression in the treatment of primary trigeminal neuralgia
Objective To analyze the effect of microvascular decompression in the treatment of primary trigeminal neuralgia.Methods 120 patients with trigeminal neuralgia were all treated with microvascular decompression.The vascular compression,therapeutic effect,occurrence of adverse events and recurrence were analyzed.Results Among the 120 patients,104 cases(86.67%)had offending vessel,and 16 cases(13.33%)had no clear offending vessel.The effective rate was 95.83%(115/120).Within 1 month after surgery,the patients had facial numbness in 17 cases(14.17%),dizziness in 6 cases(5.00%),cerebrospinal fluid leakage in 1 case(0.83%),nausea and vomiting in 5 cases(4.17%),and no neuroparalytic keratitis or hearing loss occurred.At 6 months after surgery,6 cases(5.00%)recurred within 3 months,but the pain symptoms could be controlled after medication.9 patients(7.50%)relapsed within 6 months after surgery,of which 2 patients could not be controlled after administration of drugs,and the rest of the patients were stable,no obvious abnormalities were found in head CT during follow-up,and their daily life was not affected.Conclusion Microvascular decompression is effective and relatively safe in the treatment of primary trigeminal neuralgia,which is worthy of clinical application.

Trigeminal neuralgiaMicrovascular decompressionNeurological related diseasesComplications

庄志军、林国诗、周昌富、郑水顺、汪伟巍

展开 >

363000 福建医科大学附属漳州市医院神经外科

三叉神经痛 微血管减压术 神经相关性疾病 并发症

2024

中国现代药物应用
中国水利电力医学科学技术学会

中国现代药物应用

影响因子:0.862
ISSN:1673-9523
年,卷(期):2024.18(5)
  • 23